.png)
Liver Forum-MASH 21 was held on Wednesday, September 9, 2026, at Institut Pasteur in Paris, France
Materials
Introductory Remarks and Program Overview
Welcome, Program Overview, and Acknowledgements
Edyth Dwyer, Forum for Collaborative Research
Veronica Miller, Forum for Collaborative Research
Arun Sanyal, Virginia Commonwealth University
Becky Taub, Madrigal Pharmaceuticals
Session I: Patients Front & Center
The Dr. Stephen A. Harrison Patient Advocacy Fellowship: Program Update
Elena Samsonova, Fatty Liver Foundation
Session II: Industry Rapid Fire
Quantitative Imaging Committee (QUIC): Chronic Liver Disease Group, Imaging Reporting Delphi Study
Michael Middleton, UCSD Radiology
Session III: Forum Updates
ACLF Early Drug Development Webinar
Richard Moreau*, EF CLIF
Forum Project Updates
Veronica Miller, Forum for Collaborative Research
Open Discussion
All participants
Session IV: Weight Loss and Improvement in Fibrosis: Implications for NITs
Industry Updates: Mediation Analysis Approaches
Robin Mogg*, Madrigal Pharmaceuticals
Michelle Long, Novo Nordisk
The Unicorn Framework for NITs in Liver Fibrosis & How to Understand ECM Remodeling in Liver Fibrosis
Morten Karsdal, Nordic Bioscience
Panel Discussion and Open Discussion
Detlef Schuppan, Mainz University Medical Center
Alejandro Schuler, University of California Berkeley
Michael Cooreman*, Virginia Commonwealth University
Session V: RLSE and VSE
Current Status of RLSE vs VSE
Veronica Miller, Forum for Collaborative Research
Update on Forum RLSE Project
Seema Desai*, Forum for Collaborative Research
Madrigal Analysis of Multivariable NIT Associations with Fibrosis Improvement in MAESTRO-NASH
Robin Mogg*, Madrigal Pharmaceuticals
Early Clinical Progression Endpoints Manuscript
Michelle Long, Novo Nordisk
Baveno 8 Update on Risk Stratification of Cirrhosis
Laurent Castera, Université Paris Cité, Hôpital Beaujon
Forum Direction: NITs for Progression to Cirrhosis
Becky Taub, Madrigal Pharmaceuticals
Arun Sanyal, Virginia Commonwealth University
Open Discussion
All participants
Session VI: Stretch Exercise: Dissecting Digital Twins
Good Twins and Evil Twins: What "Digital Twins" Actually Do in Clinical Trials
Alejandro Schuler, University of California Berkeley
Alexia Iasonos*, Memorial Sloan-Kettering Cancer Center
Open Discussion
All participants
Session VII: Collaborative Path Forward
Collaborative Path Forward
Veronica Miller, Forum for Collaborative Research
Arun Sanyal, Virginia Commonwealth University
Becky Taub, Madrigal Pharmaceuticals
* Remote Participation
